A61M 2202/0411
T-lymphocytes
Official title: T-Lymphocytes
A61M2202/0411 (T-lymphocytes) appears on 5 US grants and 8 published applications in this corpus.
Search patents in A61M- Granted patents
- 5
- Published applications
- 8
- Assignees
- 5
- Inventors
- 14
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 2 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Microfluidic flow control using direct-current peristaltic pump17 Mar 2026US 12,576,194 B2The Regents of the University of Michigan
- Collection, genome editing, and washing of T-cell lymphocytes17 Dec 2024US 12,168,087 B2Fenwal, Inc.
- Systems and methods for closed loop, real-time modifications of patient cells20 Feb 2024US 11,904,081 B2Lupagen, Inc.
- Acoustophoresis device having improved dimensions18 Oct 2022US 11,471,581 B2The Charles Stark Draper Laboratory, Inc.
- Acoustophoresis device having improved dimensions27 Apr 2021US 10,987,462 B2The Charles Stark Draper Laboratory, Inc.
- Cell delivery injector21 May 2026US 2026/0137869 A1Bayer HealthCare LLC
- Fluid Processing Systems Including An Electroporation Device20 Feb 2025US 2025/0058029 A1Fenwal, Inc.
- Systems and methods for closed loop, real-time modifications of patient cells2 May 2024US 2024/0139393 A1Lupagen, Inc.
- Microfluidic Flow Control Using Direct-Current Peristaltic Pump29 Dec 2022US 2022/0409790 A1The Regents of the University of Michigan
- Acoustophoresis device having improved dimensions18 Nov 2021US 2021/0353844 A1The Charles Stark Draper Laboratory, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.